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Staphylococcus epidermidis and Staphylococcus aureus are opportunistic pathogens
that cause nosocomial and chronic biofilm-associated infections. Indwelling medical
devices and contact lenses are ideal ecological niches for formation of staphylococcal
biofilms. Bacteria within biofilms are known to display reduced susceptibilities to
antimicrobials and are protected from the host immune system. High rates of acquired
antibiotic resistances in staphylococci and other biofilm-forming bacteria further hamper
treatment options and highlight the need for new anti-biofilm strategies. Here, we
aimed to evaluate the potential of marine sponge-derived actinomycetes in inhibiting
biofilm formation of several strains of S. epidermidis, S. aureus, and Pseudomonas
aeruginosa. Results from in vitro biofilm-formation assays, as well as scanning
electron and confocal microscopy, revealed that an organic extract derived from the
marine sponge-associated bacterium Streptomyces sp. SBT343 significantly inhibited
staphylococcal biofilm formation on polystyrene, glass and contact lens surfaces,
without affecting bacterial growth. The extract also displayed similar antagonistic
effects towards the biofilm formation of other S. epidermidis and S. aureus strains
tested but had no inhibitory effects towards Pseudomonas biofilms. Interestingly the
extract, at lower effective concentrations, did not exhibit cytotoxic effects on mouse
fibroblast, macrophage and human corneal epithelial cell lines. Chemical analysis by
High Resolution Fourier Transform Mass Spectrometry (HRMS) of the Streptomyces sp.
SBT343 extract proportion revealed its chemical richness and complexity. Preliminary
physico-chemical characterization of the extract highlighted the heat-stable and non-
proteinaceous nature of the active component(s). The combined data suggest that the
Streptomyces sp. SBT343 extract selectively inhibits staphylococcal biofilm formation
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without interfering with bacterial cell viability. Due to absence of cell toxicity, the
extract might represent a good starting material to develop a future remedy to block
staphylococcal biofilm formation on contact lenses and thereby to prevent intractable
contact lens-mediated ocular infections.
Keywords: marine sponges, actinomycetes, Streptomyces, staphylococci, biofilms, contact lens
INTRODUCTION
Ocular devices such as intraocular lenses, posterior contact
lenses, conjunctival plugs and orbital implants have aided in
restoring and improving human vision. However, contamination
of these devices with bacterial biofilms can lead to device-
related ocular infections such as endophthalmitis, crystalline
keratopathy, corneal ulceration, keratitis, lacrimal system,
and periorbital infections (Bispo et al., 2015; Cho et al.,
2015). The National Institute of Health (NIH) estimates that
biofilms contribute to about 75% of the human microbial
infections. Biofilms are surface-associated sessile microbial
communities that are enmeshed in a self-produced extracellular
matrix composed of polysaccharides, proteins, lipids and DNA
(Flemming and Wingender, 2010; Oja et al., 2015). Compared
to the free-living planktonic counterparts, bacteria in biofilms
are 1000-fold more resistant to conventional antibiotic therapies
and host immune responses (Donlan, 2001; Otto, 2009; Burmolle
et al., 2010). The highly persistent and detrimental nature of
biofilm-associated infections and rapid emergence of multidrug
resistant strains (Barros et al., 2014; Sakimura et al., 2015)
has imposed a major burden on health-care and medical
settings. The current inexistence of effective biofilm-based
therapeutics (Bjarnsholt et al., 2013) has necessitated the need
for development of novel antibiofilm strategies for prophylaxis
and/or treatment of the multitude of biofilm-associated ocular
infections.
Staphylococci, particularly S. epidermidis and S. aureus are
the most common causative agents of device-related infections.
Infections caused by other staphylococci are far less frequent
(Otto, 2009). S. epidermidis and S. aureus are commensal Gram
positive bacteria found on human skin and nares, causing a wide
range of indwelling medical device-related infections (Rogers
et al., 2009; Uribe-Alvarez et al., 2016). The biofilm-based
lifestyle of S. epidermidis and S. aureus on medical devices is
a hallmark of the sub-acute and chronic recalcitrant infections
caused by them (Reiter et al., 2014). Biofilm formation in
S. epidermidis and S. aureus is facilitated predominantly by
the synthesis of the homopolymer polysaccharide intercellular
adhesion (PIA) by the enzymes coded by the ica locus. PIA-
independent biofilm formation, mediated by surface proteins
such as biofilm associated protein (Bap/Bhp) and accumulation
associated protein (Aap), eDNA release, autolysins and cell
sortase-anchored proteins have also been reported in several
staphylococcal strains (Otto, 2009; Archer et al., 2011; McCarthy
et al., 2015).
Marine actinomycetes represent an untapped reservoir of a
broad range of biologically active compounds of pharmaceutical
importance (Subramani and Aalbersberg, 2012; Zotchev, 2012;
Lee et al., 2014; Azman et al., 2015). Particularly, the marine
sponge-associated actinomycetes are well documented for their
intrinsic chemical repertoire (Abdelmohsen et al., 2014a; Santos-
Gandelman et al., 2014; Reimer et al., 2015). Novel secondary
metabolites with discrete biological activities have been reported
from sponge-associated actinomycetes (Abdelmohsen et al.,
2014a; Grkovic et al., 2014; Cheng et al., 2015). These
include antimicrobial (Hentschel et al., 2001; Eltamany et al.,
2014), antiparasitic (Dashti et al., 2014; Viegelmann et al.,
2014), immunomodulatory (Tabares et al., 2011), antichlamydial
(Reimer et al., 2015), antioxidant (Abdelmohsen et al., 2012;
Grkovic et al., 2014), anticancer (Vicente et al., 2015) and
anti-biofilm (Oja et al., 2015; Park et al., 2016) activities.
The extreme and dynamic conditions offered by the oceans
(differences in temperature, pH, pressure, light intensities etc.)
are the potential reasons often linked to the production of
secondary metabolites by marine actinomycetes (Abdelmohsen
et al., 2017). The frequent rediscovery of bioactive compounds
and redundancy of sample strains from terrestrial environment
has further made the marine actinomycetes as hotspots for
discovery of new compounds (Dalisay et al., 2013). Among
actinomycetes, the genus Streptomyces are considered to be the
most prolific producers of secondary metabolites for medical,
agriculture and veterinary usage (Tan et al., 2016). Over two-
thirds of natural products isolated to date are from Streptomyces
which indicates their huge biosynthetic potential and chemistry
profiles. The rich genetic and metabolic diversity, and the ability
to catabolize a wide range of compounds, has made the genus
Streptomyces to be probed for discovery of novel compounds that
could be translated to clinical applications (Hassan et al., 2016;
Ser et al., 2016; Yang and Sun, 2016; Perez et al., 2016; Zhao et al.,
2016).
In our continuing effort for discovery of anti-biofilm agents,
we employed a crystal violet-based screening method to identify
anti-biofilm activity of organic extracts generated from marine
sponge-derived actinomycetes. The biofilm forming reference
strain S. epidermidis RP62A was employed as a model for
screening. Herein we report the inhibitory effects of an
organic extract from marine sponge-associated Streptomyces
sp. SBT343 against the biofilm formation of S. epidermidis
RP62A on polystyrene, glass and contact lens surfaces. The
potential anti-biofilm activity was tested on two other strains
of S. epidermidis, four different S. aureus strains and two
different P. aeruginosa strains. The results obtained highlighted
that the extract exhibited potent anti-biofilm effects on all the
staphylococcal strains tested but did not exert any effect on the
Pseudomonas strains. Preliminary evaluations on the physico-
chemical characterization of active component(s) in the extract
suggested their heat stable and non-proteinaceous nature.
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MATERIALS AND METHODS
Pathogenic Strains and Growth
Conditions
Bacterial strains used in the study are listed in Table 1. All strains
for the biofilm study were propagated in Tryptic Soy Broth (TSB;
Becton Dickinson) (17.0 g/l pancreatic digest of casein, 3.0 g/l
papaic digest of soybean meal, 5.0 g/l sodium chloride, 2.5 g/l
dipotassium hydrogen phosphate, 2.5 g/l glucose) and incubated
at 37◦C.
Fermentation Conditions and Extract
Preperation
Streptomyces sp. SBT343 was cultivated from the Mediterranean
sponge Petrosia ficiformis that was collected offshore Pollonia,
Milos, Greece (N36.76612◦; E24.51530◦) in May 2013 (Cheng
et al., 2015). Briefly, 1% (v/v) inoculum of a well grown culture of
Streptomyces sp. SBT343 was inoculated in 150 mL modified ISP2
medium (2.5 g/l malt extract, 1.0 g/l yeast extract, D-mannitol
25 mM, in artificial sea water) in a 250 mL conical flask and the
strain was subjected to batch fermentation (incubation at 30◦C
with shaking at 150 rpm) for 10 days. After harvesting, the filtrate
of the fermented culture was extracted twice with 250 mL ethyl
acetate for each time. The extract was generated by evaporating
the solvent in a rotational evaporator (Heidolph Laborota, 4001,
Büchi Vacuum Controller V-805). The modified ISP2 broth
medium control ensured the purity of the fermentation and was
also extracted separately in a similar manner and this served
as the medium control for the bioactivity testing. Extracts were
dissolved in DMSO (final concentration 3.75% on the cells) and
used for anti-biofilm assays.
Quantification of Biofilm Formation
Quantification of biofilm formation was performed according to
Weisser et al. (Weisser et al., 2010). Briefly, overnight culture
of bacterial strains were diluted with TSB medium to OD600 of
0.05, and incubated statically in a 96-well flat bottom polystyrene
plate (Greiner bio-one, GmbH, Germany) with or without the
varying concentrations of the Streptomyces sp. SBT343 extract
(0, 31.25, 62.5, 125, and 250 µg/ml) at 37◦C (for S. epidermidis
and P. aeruginosa) or 30◦C (for S. aureus) for 24 h. Extract
from the modified ISP2 medium control (250 µg/ml) served
as the control for the experiment. For biofilm quantification,
planktonic bacteria were discarded, and the wells were rinsed
carefully with sterile 1X phosphate buffered saline (PBS) twice,
and the adherent cells in the plate were heat-fixed at 65◦C for
1 h. This was followed by staining with 0.3% crystal violet for
5 min. The stained biofilm was washed with sterile water thrice.
Plates were dried in an inverted position and OD492 readings
were measured to compare the extent of biofilm inhibition in
the extract treated sets vs. the modified ISP2 medium control
treated set. The biofilm-negative S. epidermidis (ATCC12228)
and S. carnosus TM300 served as the negative controls in the
experiment.
Effect of the Extract on Existing Biofilms
To study the effect of the Streptomyces sp. SBT343 extract on
the existing biofilm, biofilms were established by incubating the
bacteria (inoculation OD600 0.05) in TSB medium in a 96-well flat
bottom polystyrene plate at 37◦C or 30◦C for 24 h. Planktonic
bacteria were discarded by inverting the plate on paper stacks.
This was followed by addition of fresh TSB medium with varying
concentration of the Streptomyces sp. SBT343 extract and the
plate was again incubated statically at 37◦C or 30◦C for 24 h.
The effect of the extract in eradication of preformed biofilm
by the extract was measured by the crystal violet assay as
explained above. Extract from the modified ISP2 medium control
(250 µg/ml) and sodium metaperiodate (40 mM) served as the
negative and positive controls in the experiment.
Growth Measurements
The effect of Streptomyces sp. SBT343 extract on the growth
of staphylococcal strains was evaluated (Nithya et al., 2010) by
growth curve analysis. The growth curves were determined up
to 24 h. The extract at 50% biofilm inhibitiory concentration
(BIC50) and the highest tested concentration (125 µg/ml) (non-
toxic to cell lines), was added to a conical flask containing
bacteria at an OD600 of 0.1. The flasks were incubated 37◦C under
shaking conditions at 200 rpm. TSB medium without the bacteria
served as negative control. Growth medium with the modified
ISP2 medium extract (125 µg/ml) and bacteria served as the
TABLE 1 | Strains used in this study.
Strain Description Reference and/or source
S. epidermidis ATCC 12228 Non-infection associated strain ATCC collection
S. carnosus TM300 Meat starter culture Rosenstein et al., 2009
S. epidermidis RP62A Reference strain isolated from intra-vascular catheter associated sepsis ATCC collection
S. epidermidis O-47 Clinical isolate from septic arthritis Heilmann et al., 1996
S. epidermidis 1457 Clinical isolate from a patient with infected central venous catheter Mack et al., 1992
S. aureus SH1000 MSSA; rsbU derivative of 8325-4 rsbU+ Horsburgh et al., 2002
S. aureus RN4220 Restriction-deficient transformation recipient; originally derived from NCTC 8325-4 Kreiswirth et al., 1983
S. aureus Newman MSSA isolate from osteomyelitis patient Lipinski et al., 1967
S. aureus USA300 CA-MRSA isolate from a wrist abscess McDougal et al., 2003
P. aeruginosa PAO1 Clinical isolate from wound Dr. Vinay Pawar, Braunschweig, Germany
P. aeruginosa PA14 Clinical isolate from burn wound Dr. Vinay Pawar, Braunschweig, Germany
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control. The reading was observed continuously up to 24 h at 2 h
intervals. The experiment was carried out with three independent
cultures.
Investigation on the Appearance of
Biofilm-Switches Upon Extract
Treatment
In order to study the appearance of biofilm-switches [PIA-
dependent to PIA-independent (protein-mediated) biofilms] in
the presence of the extract, the residual biofilms after the extract
treatments were challenged with metaperiodate (40 mM NaIO4)
for PIA-dependent and proteinase K (1 mg/ml in 100 mM Tris-
Cl) for PIA-independent (protein-mediated) modes of biofilm
formation with the procedure described elsewhere (Wang et al.,
2004).
Scanning Electron Microscopy
In order to evaluate the effect of the extract on the biofilm
formation on soft contact lens (Proclear R©, CooperVision R©
Lensbest, Germany), round pieces (diameter of 6 mm) were
punched out of each contact lens using a sterile puncher. Each
piece was washed twice with sterile 1XPBS and placed in a
24 well plate (Greiner bio-one, GmbH, Germany) containing
1 mL of S. epidermidis RP62A (OD600 0.05) in TSB with the
extract (at concentrations of 62.5, 125, and 250 µg/ml). For
testing the effect of the extract on the biofilm formation on
glass surface, sterile glass cover slips (diameter of 12 mm)
were placed in a 24 well plate containing 1 mL S. epidermidis
RP62A (OD600 0.05) in TSB with the extract (at concentrations
of 62.5, 125, and 250 µg/ml). In each case, bacteria treated
with extract (250 µg/ml) from modified ISP2 medium served
as the control, while wells with the TSB and the contact lens
or cover slips alone served as sterile controls, respectively.
Plates containing the contact lens and cover slips sets were
then incubated statically at 37◦C for 24 h. Samples were
then washed carefully with sterile 1XPBS twice, and fixed
overnight with 6.25% gluteraldehyde (in 50 mM phosphate
buffer pH 7.4). After overnight fixation, samples were washed
5 times with Sörenson buffer (100 mM KH2PO4 and 100 mM
Na2HPO4) and transferred to the electron microscopy unit,
where they were dehydrated and then coated with gold by a
low vacuum sputter coating, and scanned by scanning electron
microscopy.
Confocal Microscopy
Samples on the contact lens and the cover slips were prepared
and treated as above. After overnight incubation in 24 well
plates, samples were subjected to a rapid epifluoroscence staining
method employing the bacterial viability kit Live/Dead Bac
Light, Invitrogen Ltd., Paisley, UK. The kit employs Syto
9 green and propidium iodide red fluorescent nucleic acid
stains for distinguishing live and dead cells, respectively. The
dye was prepared and added to the samples according to
the manufacturer’s specifications. Samples with the dye were
incubated in the dark for 15 minutes and then assessed by
a confocal microscope. The final step comprised of acquiring
photographs of the samples with a Leica Microystems (Leica
TCS SP5, Leica Microsystems, Germany) at excitation levels
of 488 nm for Syto 9 and 543 nm for propidium iodide.
Images were acquired at 1.5 µm intervals. Further, images
representing two dimensional [compressed z series (x–y sides)
and compressed (x–z) views] and three dimensional views
of the biofilm were acquired with IMARIS v 8.1.2. The
thickness of the biofilms was also calculated with IMARIS
v 8.1.2.
Cytotoxicity Studies
Human Epithelial Corneal Cells (HCEC) were cultivated
in DMEM/Ham’s F12 (Invitrogen Life Technologies, USA),
supplemented with 5% (v/v) FBS, 1% (w/v) L-glutamine,
0.4% (w/v) antibiotics (50 U/ml penicillin and 50 mg/ml
streptomycin), insulin (5 mg/l) and EGF (10 µg/l) (PAA
Laboratories GmbH, Austria). To assess the cytotoxicity on
HCEC, vitality assay was performed with slight modifications
(Schmitt et al., 2002). Briefly, vitality staining was performed with
different concentrations of SBT343 extract for 24 h. 3.5× 105 cells
were seeded in 6-well plates for 24 h in a control medium. After
treatment, cells were collected, and 70 µl of the cell suspension
was stained with 30 µl staining solution [Gel RedBiotrend (Köln,
Germany) and fluorescein diacetate (Kreiswirth et al., 1983)].
Twenty microliter of this mixture was applied to the slide, and the
fractions of green and red cells in a total of 200 cells were counted
at a 500-fold magnification with a fluorescence microscope.
Macrophage (J774.1) and mouse fibroblast (NIH/3T3) cell lines
were cultured in RPMI 1640 (1X)+GlutamaxTM-I and DMEM
(1X)+GlutamaxTM-I (Life TechnologiesTM,USA) supplemented
with 10%FCS, without antibiotics. Cytotoxicity on J774.1 and
NIH/3T3 was assesssed employing alamar blue assay (Huber
and Koella, 1993). 1 × 105 cells/ml were seeded in 96-well
plates containing the extract at different concentrations (ranging
from 31.25 to 500 µg/ml) and were incubated for 24 h at
37◦C with 5% CO2. After incubation, 20 µL alamar blue
(Thermofischer scientific, USA) was added to each well and
the plates were further incubated for 24 h at 37◦C with 5%
CO2. Finally, the OD550 values of the plates were measured
and normalized with OD630 values. The extent of cytoxicity
was determined by comparing the extract treated sets with
the control. The final DMSO concentration on the cells
was 1%.
Physico-chemical Characterization of
Anti-biofilm Component(s)
To understand the nature of the active component(s), the extract
was subjected to thermal and enzymatic (proteinase K and
trypsin) treatments. Briefly, the extract was subjected to heat
treatments at 50, 75, and 100◦C for 1 h and cooled on ice.
For the enzymatic treatment, proteinase K or trypsin (at a
final concentration of 1 mg/ml) was added to the extract (at
a final concentration of 0.125 mg/ml) and the reactions were
incubated for 1 h at 37◦C. As controls, extracts were incubated
for 1 h at 37◦C without the enzymes, a treatment that did not
impair the anti-biofilm effect. For each of the above tests, the
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biofilm inhibitory effects of treated and untreated extracts were
compared using the microtitre plate assay (for biofilm formation)
against all the staphylococcal strains tested. Each data point
is composed of three independent experiments performed in
quadruplicate.
In parallel, the activity of proteinase K and trypsin (1 mg/ml
each) in the presence of DMSO were independently assessed
employing the quantitative azocasein assay (Hasegawa et al.,
2008).
Quantitative RT-PCR
After complementation of S. epidermidis RP62A with SBT343
extract at 62.5 (BIC50) and 250 µg/ml for 24 h at 37◦C,
total RNA was isolated from planktonic bacteria and those in
biofilm employing Trizol reagent (Invitrogen, Paisley, UK) and
FastPrep R© disrupter (Thermo Savant, Qbiogene, Inc., Cedex,
France). Firstly, 1 ml of cells (from planktonic and biofilm states;
the biofilm was gently removed from 24 well plate using a
sterile scraper and re-suspended in 1 ml of fresh TSB medium)
were centrifuged at 13000 rpm for 10 min at 4◦C and pellets
were re-suspended in 1 ml Trizol reagent. This suspension was
briefly homogenized in a Lysing Matrix E tube (MP Biomedicals
Germany, GmbH, Eschwege, Germany) in the FastPrep R© cell
disrupter and subjected to chloroform-based RNA extraction
method. Purity and concentration of the extracted total RNA
was spectrophotometrically assessed using a NanoDrop ND-
1000 (peqLab Biotechnologie, GmbH). The A260/A280 values of
(range 1.8–2.0) indicated the purity of the RNA samples and
the mean RNA yield obtained was 182.63 µg/ml. All the RNA
samples were digested with DNase I (Thermo Scientific). Briefly,
1 µg of RNA was digested with 1 µl of DNase by incubation
at 37◦C for 30 min. This was followed by addition of 1.5 µl
of DNase stop solution (50 mM EDTA) and incubation at
70◦C for 10 min. After quality assessment of RNA after DNase
treatment, about 50 ng/µl of RNA was used as template for qPCR
experiment.
cDNA synthesis and qPCR amplification was performed
simultaneously by employing the power SYBR R© Green RNA-to-
CTTM 1-step kit (Applied Biosystems, GmbH, Germany). Primers
used in the study were designed according to the literature
(Reiter et al., 2014), and were commercially produced (Eurofins
MWG Synthesis GmbH, Germany). These primers were chosen
based on their thermodynamic and sequence parameters. The
reaction mixture for qPCR contained 1 µl of RNA template,
5 µl of power SYBR R© Green RTPCR mix, 1 µl each of forward
and reverse primers (10 µM), 0.08 µl of reverse transcriptase
provided by the manufacturer and 1.92 µl of RNase free water.
qPCR was performed using the Bio-Rad C1000 TouchTM thermal
cycler with the following cycle parameters: holding stage of
48◦C for 30 min and 95◦ C for 10 min, followed by 50 cycles
of 95◦C for 15 s and then 55◦C for 1 min, with a final
melting curve determination. Experiment was peformed with
three technical and biological replicates each. A difference of
≥7 Ct (cycle threshold) between the cDNA sample and no-
template PCR control was considered negligible for relative
quantification analysis. Finally, the relative expression of the
target genes (IcaA and IcaR) in the presence of SBT343 extract
in relation to the modified ISP2 extract treated control was
determined using the comparison with the expression level of
the reference gene, DHFR (the expression of DHFR gene stayed
constant in the conditions tested). The significance of the relative
quantification was assessed by Student’s t-test (GraphPad Prism R©
version 6.01).
Statistical Analysis
Experiments were repeated at least three times in quadruplicates
and the data were expressed as mean ± standard error mean.
The Student’s t-test was used and p < 0.05 was considered as
statistically significant. GraphPad Prism R© version 6.01 was used
for statistical analysis of the experimental data.
LC-MS Analysis
Analytical grade reagents, Methanol (MeOH), dichloromethane
(DCM), acetonitrile (MeCN), and formic acid were purchased
(Fisher Scientific, Hemel Hempstead, UK). In-house HPLC
grade water was used from a direct Q-3 water purification
system (Millipore, Watford, UK). Samples and medium control
samples were prepared at a concentration of 1 mg/mL
in 80:20 MeOH: DCM with a solvent blank. Experiments
were performed with an Exactive mass spectrometer with
an electrospray ionization source attached to an Accela 600
HPLC pump with Accela autosampler and UV/Vis detector
(Thermo Scientific, Bremen, Germany). The mass accuracy
was set to less than 3.0 ppm. The Orbitrap mass analyzer
can limit the mass error within ±3.0 ppm. The instrument
was calibrated to maintain a mass accuracy of ±1.0 ppm
by applying the lock mass function. The instrument was
externally calibrated per the manufacturer’s instructions before
the run and was internally calibrated during the run using
lock masses. Mass spectrometry was carried out over a mass
range of 100–2000 m/z in positive and negative ionization
modes with spray voltage of 4.5 kV and capillary temperature
at 270◦C. Ten microliter were injected from each vial, at
a flow rate of 300 µL/min. The column used was an
ACE5 C18 column (5 µm × 75 mm × 3 mm) (Hichrom
Limited, Reading, UK). A binary gradient method was utilized.
The two solvents were A (water and 0.1% formic acid)
and B (MeCN and 0.1% formic acid). The gradient was
carried out for 10 min and the program followed; at zero
minutes A = 90% and B = 10%, at 30 min A = 0%
and B = 100% at 36 min A = 90% and B = 10% until
end at 45 min. The UV absorption wavelength was set at
254 nm, the sample tray temperature was maintained at 4◦C
and the column maintained at 20◦C. The samples were run
sequentially, with solvent and media blanks analyzed first. LC-
MS data was acquired using Xcalibur version 2.2 (Thermo
Scientific, Bremen, Germany). LC-MS chromatograms were
subsequently obtained using MassLynx v 4.10. This was followed
by dereplication strategy. Since, the modified ISP2 medium is
a complex mixture of constituents and could interfere with the
identification of secondary metabolites in the SBT343 extract,
a medium blank was analyzed together with the bacterial
extract and obtained features were regarded as interference and
subtracted for detection of true bacterial secondary metabolites.
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FIGURE 1 | (A) Dose dependent inhibition of Streptomyces sp. SBT343 extract on biofilm formation of S. epidermidis RP62A on polystyrene flat-bottom 96-well
plates. S. epidermidis RP62A treated with the extract from modified ISP2 medium (250 µg/ml) served as the appropriate control in the experiment. (B) Growth curve
of S. epidermidis RP62A in the presence of BIC50 (62.5 µg/ml) and highest tested concentration (125 µg/ml) of the SBT343 extract. (C) Investigation of the
Streptomyces sp. SBT343 for induction of PIA-independent biofilm formation in S. epidermidis RP62A. Control and the residual biofilms after the extract treatment
(250 µg/ml) were subjected to two parallel treatments (i) with metaperiodate (NaIO4−T), which is suitable to dissolve the PIA-matrix proportion of the biofilm, and (ii)
with proteinase K (proteinase K−T) which will reduce proteins engaged in the biofilm matrix. Biofilm measurements were done shortly after the respective treatments,
and the total biofilm levels were compared with the untreated control and residual biofilm sets. The biofilm-negative S. epidermidis ATCC12228 served as the
negative control. S. epidermidis RP62A treated with the extract from modified ISP2 medium (250 µg/ml) served as the appropriate control. Graphs represent mean
values ± SEM from three independent repetitions of the experiment done in quadruplicate. ns, not significant, ∗∗∗∗p < 0.0001.
Finally, the m/z values were searched for possible hits in the
MarinLit R© database (Abdelmohsen et al., 2014b; Macintyre et al.,
2014).
RESULTS
Anti-biofilm Effect of the Streptomyces
sp. SBT343 Organic Extract
Our continuing effort for discovery of anti-biofilm agents
from marine sponge-derived actinomycetes against the model
isolate S. epidermidis RP62A, led to identification of the anti-
biofilm Streptomyces sp. SBT343 extract. The presence of the
extract at 31.25 µg/ml during the bacterial growth caused a
significant (p < 0.0001) reduction in the biofilm formation
after 24 h of growth. At 62.5 µg/ml about 50% of the
biofilm formation was inhibited and this was designated as
the Biofilm Inhibitory Concentration (BIC50). The anti-biofilm
activity of the extract was dose-dependent, leading to 71.35%
inhibition of biofilm formation at the maximum concentration
(250 µg/ml) tested (Figure 1A). Even after the addition of
extract at BIC50 and highest tested concentration, the growth
of S. epidermidis RP62A was at the same level as that of the
control. These results confirm that the biofilm inhibition by
the extract is not due to growth effect (Figure 1B). SBT343
extract showed no effect on detaching/dispersing the bacteria
from preformed biofilm at any of the tested concentrations (data
not shown).
As the strain S. epidermidis RP62A is known as a
strong PIA matrix biofilm producer, SBT343-mediated biofilm
inhibition strongly suggests interference with PIA-mediated
biofilm formation. Since, staphylococci are known to switch from
PIA-dependent to PIA-independent biofilm formation under
different conditions; the presence of these spontaneous switches
in the presence of the extract was assessed. The ineffectiveness of
proteinase K treatment on residual biofilms highlight that there is
no spontaneous switch from PIA-dependent to PIA-independent
(protein-mediated) biofilm formation in the presence of SBT343
extract (Figure 1C).
SEM Analysis
The biofilm inhibition potential of the SBT343 extract was
studied on glass and contact lens surfaces using microscopic
techniques. Electron microscopy of biofilm formation on glass
cover slips and contact lenses in the presence of 62.5, 125,
and 250 µg/ml SBT343 extract confirmed the results obtained
by the in vitro crystal violet assay (Figure 2). In the control
glass cover slips, mushroom shaped, three-dimensional biofilm
was observed, whereas, multi-layered biofilm was observed on
control contact lenses. In the glass cover slips and contact lenses
incubated with the SBT 343 extract (62.5, 125, and 250 µg/ml),
a dose-dependent reduction in the biofilm was clearly seen
(Figure 2A). The reduction of biofilm with the extract was even
pronounced in the contact lens model suggesting its possible
application in contact lens solution and storage systems. Surfaces
were distinctly seen between sporadic microcolonies in the
glass cover slip and the contact lens incubated with higher
concentrations of the extract. Representative SEM images at
higher magnification indicated that the extract did not affect the
morphology of the staphylococcal cells. Further, the presence
of fibrous, net-like structures in the biofilm matrix was greatly
reduced in both the glass cover slips and contact lenses incubated
with SBT343 extract (Figure 2B). These findings suggest that
the extract possibly works by altering the biofilm matrix
composition or interferes with the production of extracellular
matrix.
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FIGURE 2 | Representative SEM images of staphylococcal biofilm on (A) Glass cover slip and contact lens at X1500 magnification. (B) Glass cover slip and
contact lens at X10000 magnification. The white arrows indicate the presence of fibrous, net like structures which are typical features of PIA-dependent biofilms and
the black arrows indicate the absence of the same. S. epidermidis RP62A treated with the extract from modified ISP2 medium (250 µg/ml) served as the appropriate
control in the microscopy experiments.
FIGURE 3 | Confocal laser scanning microscopy analyses of staphylococcal biofilm in the presence of the SBT343 extract, visualized by
fluorescence vital dye. Images were acquired by Leica TCS SP5 with a 20X objective lens (scale bar 30 µm). (A) Biofilm images on the glass cover slip. (B) Biofilm
images on contact lens. In (A,B), compressed z series (top), where multiple x–y planes from top to bottom of the biofilm are combined and the smaller image
(bottom) represents the compressed x–z (side) of the biofilm. The thickness of the biofilms in control was 28.7 µm, whereas after extract treatment it was only
15.1 µm (62.5 µg/ml) and 4.53 µm (125 µg/ml) on the glass cover slips. Similarly, the thickness of the biofilms in the extract treated contact lens samples was only
13.6 µm (62.5 µg/ml) and 7.55 µm (125 µg/ml).
Confocal Microscopy Analysis
For the confocal microscopy studies, effect of the SBT343 extract
on the biofilm formation was also examined with two systems,
first in the cover slips, where the control sample showed compact
and condensed biofilm, while the treatment with the extract
attenuated the formation of the biofilm in a dose dependent
matter. The same observations were obtained in the contact
lens as a second system for examination. The ability of the
extract to inhibit the biofilm formation was stronger in the
coverslips experiments in comparison to the contact lens, but
in both systems the inhibition was significant in comparison to
the control (Figure 3). Noteworthy, very few non-viable bacteria
(stained red) were spotted in the experiment both in the treated
and the untreated sets. This further confirms that the extract
does not interfere with bacterial cell viability. As a control, cells
in biofilm were exposed to 75% ethanol for 5 mins and stained
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with propidium iodide and SYTO green. In this case a large
population of dead cells were spotted in the microscope (data
not shown). Images representing compressed x–y and x–z (side)
views (Figure 3) indicated that the number of the bacteria in the
biofilm and the total biofilm thickness in the extract treated cover
slips and contact lens sets were greatly reduced in comparison
with the compact and condensed biofilm control. These images
further corroborated the results that the reduction in fluorescence
in the presence of the extract, was primarily due to the repression
of biofilm formation, and has no negative effects on bacterial cell
viability.
Anti-biofilm Effect of SBT343 Extract on
Other Pathogens
The anti-biofilm activity of the SBT343 extract was investigated
with other biofilm-forming S. epidermidis, S. aureus, and
P. aeruginosa strains (Table 2). SBT343 extract (125 µg/ml)
significantly reduced the biofilm formation of all the
S. epidermidis, MSSA and MRSA strains tested, while the
biofilm formation of P. aeruginosa was unaffected (Figure 4A).
A dose dependent reduction in biofilm formation of the
staphylococcal strains was observed upon extract treatment
(Figure 4B), while the growth of the strains were unaltered in
the presence of the extract (Figure 4C). Further, the extract had
no effects on the preformed biofilms of all the strains tested at
the highest concentration tested (data not shown). This indicates
selectivity of the extract in inhibiting staphylococcal biofilms.
Cytotoxicity Analysis
We further investigated the cytotoxicity profile of the SBT343
extract against mouse fibroblast (NIH/3T3), macrophage (J774.1)
and human corneal epithelial cells (HCEC). Results from vitality
test and alamar blue assay demonstrated that cells did not suffer
from significant toxicity after 24 h with effective concentrations
of the extract (in the range of 31.25–125 µg/ml). The highest
concentration 500 µg/ml displayed moderate to high cytotoxic
effects on the cell lines tested (Table 3).
TABLE 2 | Biofilm formation of the investigated bacterial strains employing
crystal violet assay.
Strain Biofilm (OD 492 nm)
S. epidermidis ATCC 12228 0.124 ± 0.010
S. carnosus TM300 0.204 ± 0.013
S. epidermidis RP62A 2.861 ± .0.143
S. epidermidis O-47 1.387 ± 0.044
S. epidermidis 1457 2.165 ± 0.069
S. aureus SH1000 0.994 ± 0.112
S. aureus RN4220 1.177 ± 0.092
S. aureus Newman 0.691 ± 0.149
S. aureus USA300 0.659 ± 0.031
P. aeruginosa PAO1 1.337 ± 0.101
P. aeruginosa PA14 1.331 ± 0.067
Each data point is composed of three independent experiments performed in
quadruplicate. Standard errors are reported.
Physico-chemical Characterization of
Anti-biofilm Component(s)
Preliminary physical and chemical characterization of the
biofilm inhibiting component(s) in the extract was assessed by
subjecting the extract to physical (heat) and chemical (proteinase
K or trypsin) treatments. Both the physical and chemical
treatments, did not reduce the activity of the extract against
all the staphylococcal strains (Figure 5). However, a slight
increase in the activity was observed upon heat treatment, in
S. epidermidis RP62A and 1457, and S. aureus SH1000 and
RN4220 strains. Similarly, a slight increase in the anti-biofilm
activity was observed upon enzyme treatment in S. aureus
SH1000 and RN4220 strains (Figure 5). This suggests that the
active component(s) in the extract is thermo-stable and non-
proteinaceous in nature, and the extract contains compound(s)
with anti-biofilm activity that could work similarly on different
staphylococcal strains. DMSO at the tested concentrations did
not influence proteinase K and trypsin activities (Supplementary
Figure 1).
LC-MS Analysis
To identify the putative bioactive secondary metabolites in the
SBT343 extract, the LC-UV/MS signature of the extract generated
by high resolution Fourier Transform mass spectrometry was
compared with the MarinLit database (a database for marine
natural products). The dereplication of the chemical profile of
SBT343 extract by comparison of HRMS data with MarinLit,
led to identification of several known and unknown metabolites
which were previously isolated from the genus Streptomyces.
Both the positive and negative modes of electrospray ionization
spectral data were used for dereplication purposes. The total ion
chromatogram of the SBT343 extract showing the distribution
of known and unknown compounds is depicted in Figure 6A.
Further, the known compounds detected from the dereplication
strategy are mentioned in Table 4 and their structures are
depicted in Figure 6B.
DISCUSSION
Biomaterials used in clinical and medical settings are ideal
niches for formation of microbial biofilms (Shanmughapriya
et al., 2012). Even though a number of natural and synthetic
anti-biofilm agents have already been discovered (Richards and
Melander, 2009; Gupta et al., 2016; Miquel et al., 2016; Tran et al.,
2016), none of them has entered the market, owing to obstacles
in translational research and lack of interest by pharmaceutical
and biomedical companies (Romero and Kolter, 2011). Hence,
there is a large unmet need for development of anti-biofilm
formulations to tackle the problem of biofilms.
Various culture dependent and independent techniques
have revealed the bacterial biofilm diversity in contact lens-
related corneal diseases (Hall and Jones, 2010; Wiley et al.,
2012). Staphylococci, particularly S. epidermidis, are frequent
contaminants of a range of ocular devices. It was estimated by
Hou et al. (2012) that many ophthalmic isolates of S. epidermidis
could form biofilms in vitro. Strong biofilm formation by
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FIGURE 4 | Anti-biofilm effect of SBT343 extract on other staphylococcal strains. (A) Photographs of wells of 96-well plate showing biofilms in the absence
and presence of SBT343 extract after crystal violet staining. Control (modified ISP2 medium extract: 125 µg/ml) and SBT343 extract treated (125 µg/ml). (B) Dose
dependent inhibitory effect of Streptomyces sp. SBT343 extract on biofilm formation of other staphylococcal strains on polystyrene flat-bottom 96-well plates.
Staphylococcal strains treated with the extract from modified ISP2 medium (250 µg/ml) served as the appropriate control in the experiment; (C) Growth curves of
staphylococcal strains in the presence of BIC50 and highest tested concentration (125 µg/ml) of the SBT343 extract. Graphs represent mean values ± SEM from
three independent repetitions of the experiment done in quadruplicate. ns: not significant, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001.
S. epidermidis has been observed on various intraocular and
contact lens (IOLs) materials (Okajima et al., 2006). Bacteria
in the biofilms of contact lenses are frequently resistant to
antimicrobials in the soft contact lens care products (Szczotka-
Flynn et al., 2009). This has sharpened the need to develop new
anti-biofilm-based contact lens products for combating ocular
infections. The anti-biofilm potential of natural product based
preparations, extracts, and compounds have increasingly been
reported in in vitro biomaterial-based models (Pacheco da Rosa
et al., 2013; Nair et al., 2016). Several researchers have tried to
assess the anti-biofilm aspects of marine bacteria (Nithya et al.,
2011; Gowrishankar et al., 2012; Papa et al., 2015; Wu et al., 2016),
particularly, marine actinomycetes (Oja et al., 2015; Saleem et al.,
2015; Park et al., 2016).
Leshem et al. (2011) and Cho et al. (2015) have previously
reported the inhibitory effect of natural product based extract
and several compounds on staphylococcal biofilm formation
on contact lens and contact lens cases. We have shown that
the organic extract from marine Streptomyces sp. SBT343
exhibits similar anti-biofilm effects at much lower concentrations
(62.5–250 µg/ml). The extract had no adverse effects on the
contact lens material at the highest concentrations tested (data
not shown). At the same time, the lowest effective concentration
of the extract did not show apparent cytotoxic effects on the three
different cell lines tested which indicates the possibility of using
the extract for the human subjects. The selective anti-biofilm
effect of the SBT343 extract against different staphylococcal
strains without interference with the bacterial cell growth
suggests the less possible appearance of resistant mutants with the
usage of this extract. However, further experiments are needed to
prove this hypothesis. The basis of employing TSB medium as
the growth medium in the study is to provide optimal growth
conditions at which the effects of SBT343 extract could be
determined in short periods.
Under certain conditions, S. epidermidis is known to switch
between the PIA-dependent and independent modes of biofilm
lifestyle (Rohde et al., 2005; Hennig et al., 2007). Our findings
TABLE 3 | Cytotoxic evaluation for SBT343 extract.
Cell line % reduction in cell viability
500 µg/ml 250 µg/ml 31.25–125 µg/ml
HCEC 90.75 ± 1.23∗∗∗∗ 20.66 ± 5.10∗ NC
NIH/3T3 21.56 ± 2.43∗∗∗∗ NC NC
J774.1 33.83 ± 2.27∗∗∗∗ NC NC
Each data point is composed of three independent experiments performed in
quadruplicate. Standard errors are reported. Differences in mean were compared
to untreated control and considered statistically significant when p (∗p < 0.05,
∗∗∗∗p < 0.0001) as per Student’s t-test. NC, not cytotoxic.
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FIGURE 5 | Physico-chemical characterization of anti-biofilm component(s). (A) Influence of heat treatment on anti-biofilm activity. UT, untreated; HT, heat
treated. (B) Influence of enzyme treatment on anti-biofilm activity. UT, untreated; PKT, proteinase K treated; TT, trypsin treated. ns, not significant; ∗∗∗∗p < 0.0001.
suggest that there are no switches in the biofilm lifestyle of
the organism in the presence of the extract (Figure 1C). For
a better understanding of the mechanism of biofilm inhibition
by the extract, the relative mRNA expression of icaA and icaR
in S. epidermidis RP62A (after 12 and 24 h) was determined
in the planktonic and the biofilm cells in the presence of the
extract. However, no significant changes in the expression levels
of icaA and icaR were noted in the extract treated planktonic
and biofilm cells (data not shown). These results indicate that
the extract possibly works by an alternate mechanism and a
global gene expression analysis would assist in deciphering the
exact mode of action of the extract. The universal anti-biofilm
activity against different staphylococcal strains with no effects on
preformed biofilm and low cytotoxicity of this extract suggests its
potential usage in contact lenses storage cases to prevent contact
lens-associated ocular infections. Further studies are necessary to
determine the anti-biofilm effect of SBT343 extract on different
contact lens and storage cases materials.
The preliminary physical and chemical characterization of
the anti-biofilm component(s) in the extract indicates that the
active component(s) is of thermo-stable and non-proteinaceous
nature and could act similarly on different staphylococcal strains
tested. Dereplication strategies are often used in the natural
products-based research for rapid identification of secondary
metabolites in the crude bacterial extracts (Abdelmohsen et al.,
2014b; Cheng et al., 2015). Currently, several analytical methods
and tools are available for dereplication of metabolites in complex
mixtures. Comparison of the HRMS data at positive and negative
modes with the MarinLit database resulted in identification of
several putative compounds in the Streptomyces sp. SBT343
extract. It is clear from the chromatogram that several peaks
were not identified by comparison to the database, including
some of the major components that showed strong peak
intensity and good resolution. The high number of unidentified
compounds highlights the chemical potential of this strain as
a source of new natural products. Most of the compounds
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FIGURE 6 | (A) Total ion chromatogram of crude extract of Streptomyces sp. SBT343 in both positive and negative modes, annotated to indicate metabolites
identified in Table 4. Annotation and dereplication was done by eliminating the metabolites from the extract of modified ISP2 medium. Those annotated with an
asterisk ∗ are sodium ion adducts. (B) Structures of the putatively identified and dereplicated compounds.
identified in the extract were previously isolated from marine
Streptomyces. An extensive literature search on the biological
activities of these compounds revealed that none of them have
been tested/reported to have anti-biofilm effects, while several of
the putative compounds identified are known to possess anti-
fungal, anti-cancer, anti-mycobacterial and anti-malarial effects.
TABLE 4 | Putatively identified and dereplicated compounds from the
high-resolution mass spectral data sets of the crude ethyl acetate extract
of Streptomyces sp. SBT343 using MarinLit R© database with a precision of
±0.1–1.0.
Peak ID ESI Mode m/z∗ Rt (min) Hits (m/z∗∗)
1 P 1095.624 5.85 Azalomycin (1095.682)
2 P 325.197 3.44 Streptcytosine B (325.109)
3 P 307.187 3.83 Streptcytosine C (307.153)
4 P 350.098 5.03 Daryamide A (350.184)
5 N 510.265 4.85 Azamerone (510.168)
Antimycin B1 (510.221)
6 N 272.154 3.38 Usabamycin A (272.152)
7 N 659.355 5.15 Actinoramide D (660.738)
P, positive ESI mode; N, negative ESI mode; Rt, retention time; ∗ indicates
the neutral m/z values of peaks found in the crude ethyl acetate extract of
Streptomyces sp. SBT343; ∗∗ indicates the m/z values of the corresponding hits
identified with the MarinLit R© database.
This further highlights the novelty in discovery of compound(s)
with specific anti-biofilm effects from the SBT343 extract. Up-
scaling of the fermentation process and consequent bio-assay
guided fractionation would help in isolation and identification
of active compound(s) in the extract. In conclusion, our
results show that the chemically rich Streptomyces sp. SBT343
extract has the potential to prevent the staphylococcal biofilm
formation on polystyrene, glass, and contact lens surface without
exhibiting toxic effects on bacterial and mammalian cells. Future
characterization of lead compounds in this extract may yield
novel anti-biofilm compound(s) of pharmaceutical interest.
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